Skip to main content Skip to main navigation
Government logo | to homepage of National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • Nederlands
  • English
  • Home
  • News

News


Search

Fill in your search phrase.

Topics

  • (-) WHO Collaborating Centre for Antimicrobial Resistance Epidemiology and Surveillance (11)
  • (-) Population screening programmes (7)
  • (-) Occupational Safety (5)
  • (-) PFOA (1)
  • International (262)
  • COVID-19 vaccination (159)
  • COVID-19 (149)
  • National Immunisation Programme (22)
  • Immunisation and vaccination (21)
  • Antimicrobial resistance (19)
  • Tobacco (19)
  • Air (17)
  • Circular economy (17)
  • COVID-19 (14)
  • Zoonotic diseases (14)
  • Heat (13)
  • HPV vaccination (13)
  • WHO Collaborating Centre for Tobacco Product Regulation and Control (13)
  • Flu and flu vaccine (12)
  • Healthy living environment (11)
  • Nanotechnology (11)
  • One Health (11)
  • Tick bites (11)
  • Ebola (10)
  • Food safety (10)
  • Medical devices (10)
  • WHO Collaborating Centre for Risk Assessment of Pathogens in Food and Water (10)
  • Health research for COVID-19 (9)
  • Plastics (9)
  • Nitrogen (8)
  • Sexually transmitted infections (STIs) (8)
  • Soil and water (8)
  • Tuberculosis (8)
  • Measles (7)
  • Mpox (7)
  • PFAS (7)
  • Sustainability (7)
  • Sustainable Development Goals (7)
  • WHO Collaborating Centre on Chemical Food Safety (7)
  • Food and Nutrition (6)
  • Public Health Foresight (6)
  • Salmonella (6)
  • Tick-borne encephalitis (6)
  • MERS-coronavirus (5)
  • WHO Collaborating Centre for Nutrition (5)
  • Accidents and disasters (4)
  • Biobased economy (4)
  • Bisphenol A (BPA) (4)
  • Dutch National Food Consumption Survey (4)
  • Food Reformulation (4)
  • Hydrofluorocarbons (4)
  • Rubber granulate (4)
  • Alternatives to animal testing (3)
  • Chromium (VI) and CARC (3)
  • Climate change and Health (3)
  • ConsExpo (3)
  • Heel prick (3)
  • International projects (3)
  • Legionnaires' disease (Legionellosis) (3)
  • Meningococcal ACWY (3)
  • Mosquitos (3)
  • Perinatal screening (3)
  • Pharmaceuticals in the environment (3)
  • Physical Activity (3)
  • RSV (3)
  • UV ozone layer and climate (3)
  • West Nile fever (3)
  • Assistance RIVM Sint Maarten landfill (2)
  • CAESAR (2)
  • Cervical cancer screening programme (2)
  • Consumer exposure to chemical substances (2)
  • Dutch Food Composition Database (NEVO) (2)
  • Population screening programmes in the Caribbean Netherlands (2)
  • Beeldschermgebruik (1)
  • Breast Cancer Screening Programme (1)
  • Chikungunya (1)
  • Chikungunya (1)
  • Chroom-6 (1)
  • Dengue (1)
  • E-health (digitale zorg) (1)
  • GenX (1)
  • Health promotion (1)
  • HPV - Humaan Papillomavirus (1)
  • Leefstijlmonitor (1)
  • Lifestyle Monitor: public health monitoring of lifestyle and health in the Netherlands (1)
  • Meldpunt en Expertisecentrum Bijwerkingen Implantaten (1)
  • PFAS (1)
  • Pneumococci (1)
  • Polio (1)
  • Radiation exposure in the Netherlands (1)
  • Rotavirus (1)
  • Screening for Down’s, Edwards’, Patau’s syndromes and ultrasound (1)
  • Sewage research (1)
  • Sustainable procurement (1)
  • Synthetic biology (1)
  • Tata Steel (Corus) (1)
  • Veilige leefomgeving (1)
  • WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk (1)
  • WHO Collaborating Centre on Life Course and Health (1)
  • Zika Virus (1)

Publication date

  • April 2023 (1)
  • March 2023 (2)
  • February 2023 (1)
  • November 2022 (2)
  • October 2022 (1)
  • May 2022 (2)
  • May 2021 (1)
  • March 2020 (1)
  • November 2019 (1)
  • December 2018 (2)
  • July 2016 (1)
  • November 2015 (1)
  • September 2015 (1)
  • June 2015 (1)
  • February 2015 (1)
  • November 2014 (1)
  • June 2014 (2)
  • November 2013 (2)

From 1 October 2023, heel prick test also screens for metabolic disorder ALD

From 1 October 2023, the blood of newborn babies will also be tested for the metabolic disorder adrenoleukodystrophy (ALD). This is done with the heel prick screening test.
04/18/2023 - 08:40

Night shift workers more likely to have poor work-life balance

People who work at night are more than 2.5 times more likely to have a poor work-life balance. They find it more difficult to combine their jobs and private lives than people who only work in daytime. This is one of the results of a study by RIVM and TNO.
03/31/2023 - 09:22

NIPT available as standard option for all pregnant women from 1 April

From 1 April 2023, the Non-Invasive Prenatal Test (NIPT) will be available to all pregnant women. They do not have to take part in a scientific study for this.
03/27/2023 - 08:55
Arts overleg met toekomstige ouders

RIVM and TNO describe impact of future developments on occupational health and safety

RIVM and the Netherlands Organisation for Applied Scientific Research (TNO) have investigated the potential impact of developments in the next 20 years on occupational health and safety. How will artificial intelligence affect safety at work?
02/03/2023 - 10:00
iStock

Safe working practices: RIVM creates a list of 1,400 substances without a European occupational exposure limit for health purposes

Employees sometimes come into contact with hazardous substances at work. RIVM has compiled a list of 1,400 hazardous substances for which the European Commission has not yet set an occupational exposure limit.
11/24/2022 - 14:20

NS did not adequately protect employees from exposure to chromium (VI)

Employees of Dutch Railways (NS) may have been exposed to chromium (VI) between 1970 and 2020. Although it is not known exactly how often or how much this occurred, it is reasonable to assume that NS employees who were exposed to chromium (VI) may develop certain medical conditions.
11/23/2022 - 11:20

Cancer screening programmes now more accessible to transgender and intersex persons

Since October 2022, is it has become easier for transgender and intersex persons to take part in cervical cancer screening and breast cancer screening. Transgender and intersex persons with a uterus and/or breast tissue can register with Bevolkingsonderzoek Nederland.
10/11/2022 - 17:22
Transgender symbool

From 1 June 2022, heel prick test also screens for muscle disease SMA, bringing number of screened diseases to 26

From 1 June 2022, the heel prick test for Dutch newborns will also screen for spinal muscular atrophy (SMA). SMA is a serious hereditary muscle condition. Detecting this disease at an early stage enables early treatment.
05/20/2022 - 11:39

Tailor-made information will help immigrants make decisions on taking part in screening programmes

Immigrants are relatively less likely to take part in preventive screening programmes, such as cancer screening. This is partly due to the language barrier and a lack of knowledge, according to a doctoral thesis by Nora Hamdiui.

05/13/2022 - 10:03
Vier vrouwen op een pleintje

Breast cancer screening resumes on Bonaire after COVID-19 hiatus

Women aged 50 to 75 years on Bonaire can participate in the breast cancer screening programme again as of Wednesday, May 26, 2021. This was temporarily halted in 2020 due to the COVID-19 pandemic.

05/25/2021 - 15:25

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • › Next ›
  • » Last »

Share this page


  • Facebook
  • Twitter
  • LinkedIn
  • WhatsApp
  • Email

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Copyright
  • Responsible disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS reed
  • Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram